Ana V. Vazquez-Esteban

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti-IL-6 treatment.

Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti-IL-6 treatment.

Journal: Frontiers in medicine

Published: June 23, 2026

Prevalence of Psoriatic Arthritis in Patients with Moderate-to-Severe Psoriasis in the Era of Biologics and Small Molecule Therapies.

Prevalence of Psoriatic Arthritis in Patients with Moderate-to-Severe Psoriasis in the Era of Biologics and Small Molecule Therapies.

Journal: Journal of clinical medicine

Published: October 09, 2025

Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica.

Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica.

Journal: Frontiers in medicine

Published: August 20, 2025

Perception of COVID-19 vaccines in rheumatology patients.

Perception of COVID-19 vaccines in rheumatology patients.

Journal: Medicine

Published: April 08, 2025

Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors.

Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 19, 2024

The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors.

The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors.

Journal: Vaccines

Published: September 19, 2023

Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial.

Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial.

Journal: Scientific reports

Published: June 26, 2023

Raynaud's phenomenon and digital ischaemia induced by ixekizumab.

Raynaud's phenomenon and digital ischaemia induced by ixekizumab.

Journal: Rheumatology (Oxford, England)

Published: May 26, 2023

"Hiker's feet" in a patient with anti-PM-Scl autoantibodies-associated idiopathic inflammatory myopathy.

"Hiker's feet" in a patient with anti-PM-Scl autoantibodies-associated idiopathic inflammatory myopathy.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: May 22, 2022

"Hiker's feet" bei einem Patienten mit Anti-PM-Scl-Autoantikörpern und idiopathischer entzündlicher Myopathie.

"Hiker's feet" bei einem Patienten mit Anti-PM-Scl-Autoantikörpern und idiopathischer entzündlicher Myopathie.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: May 22, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026